Asher Bio Secures $55M in Series C Funding for Cancer Therapy
Key Highlights $55 million raised in Series C financing to advance AB248, a novel cancer immunotherapy. New investors include AstraZeneca…
Browsing Tag
Asher Biotherapeutics
1 post